Development

INSIGHTS ON DRUG DEVELOPMENT

Biofluorescent Particle Counters Are Gaining Momentum
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
Spray Drying With A Buchi-B290
Dr. Jordan Potts demonstrates how the Buchi B‑290 spray dryer works and explains its use in spray drying and particle engineering research.
Biophysical Tools For Biotherapeutic Development
Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.
Addressing Raw Material Handling Challenges By Dry Granulation
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.

Automating High-Throughput Screens Using Patient-Derived Organoids
3/17/2025

Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
Automation Of 3D Intestinal Organoids Culture
3/17/2025

Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs
7/29/2025

GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.
Assessing Production And Stability Of Antibody Drug Conjugate Platforms
9/24/2025

ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology
3/4/2026

Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.

Predict And Assign Fragment Ions

Model MS fragmentation pathways and align predictions with experimental data to assign fragment ions faster. Streamline spectral interpretation and confirm compound identities with greater confidence.
Medicinal Chemistry

Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.
In Vitro Biology

Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.
High-Speed Fluorescence And White Light Imaging With The CloneSelect Imager

Next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types

Demonstrating that cell lines are monoclonal – or that a gene was edited as expected – can be a time-consuming and highly-subjective process when relying on conventional technologies. The CloneSelect® Imager and CloneSelect® Imager FL are a high-throughput automated solutions for imaging and analyzing mammalian cells. Tracking the formation of a colony from a single cell is effortless as barcoded plates are tracked over time. Automated acquisition and analysis provides accurate, objective, and consistent results.
A Comprehensive Method Development Experience

Our combined method development experience ensures that client methods are robust, effective, flexible, innovative and allow true stability indication.